Evidence map›Paper›PMID 42582373›Full record

ArticleOpen forum infectious diseases2026

Association of Cannabis Use With Risk of Subsequent Falls Among Adults Aging With HIV.

Jennifer A Manuzak, Janeway Granche, Michael D Hughes, Katherine Tassiopoulos, Jamie O Lo, Benjamin J Burwitz, Joseph E Rower, Justin R Knox, John A Schneider, Ronald J Ellis and 3 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jennifer A ManuzakDivision of Immunology, Tulane National Biomedical Research Center, Covington, Louisiana, USA.ORCID https://orcid.org/0000-0002-0079-2306
Janeway GrancheCenter for Biostatistics in AIDS Research (CBAR), Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-5014-8092
Michael D HughesCenter for Biostatistics in AIDS Research (CBAR), Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Katherine TassiopoulosCenter for Biostatistics in AIDS Research (CBAR), Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-4773-2535
Jamie O LoDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Oregon Health and Science University School of Medicine, Portland, Oregon, USA.ORCID https://orcid.org/0000-0002-1934-1935
Benjamin J BurwitzDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, USA.
Joseph E RowerCenter for Human Toxicology, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0003-3629-7902
Justin R KnoxDepartment of Psychiatry, Columbia University, Irving Medical Center, Manhattan, New York, USA.ORCID https://orcid.org/0000-0001-6771-8138
John A SchneiderDepartment of Medicine, University of Chicago, Chicago, Illinois, USA.
Ronald J EllisDepartment of Neurosciences, University of California San Diego, La Jolla, California, USA.ORCID https://orcid.org/0000-0003-4931-752X
Karl GoodkinAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG), Chapel Hill, North Carolina, USA.
Anjali SharmaDepartment of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID https://orcid.org/0000-0003-3717-025X
Kristine M ErlandsonDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.ORCID https://orcid.org/0000-0003-0808-6729

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)UM1AI068634 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Marlene Ann Cooper, Michael David Hughes · 2011 to 2026
$246.6M
AIDS Clinical Trials Group NetworkU01AI068636 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI KURITZKES, DANIEL R. · 2006 to 2010
$147.1M
Validation, CLIA and Qualification (VQC): Enhancing the RS ratio as a tool for AIDS Clinical Trial Group (ACTG) tuberculosis trialsUM1AI106701 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$116.8M
Statistical and Data Management Center for the AIDS Clinical Trials GroupU01AI068634 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI HUGHES, MICHAEL DAVID · 2006 to 2010
$71.9M
UCSD Department of Medicine HIV/AIDS Clinical Trials UnitUM1AI069432 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TIMOTHY J. WILKIN · 2012 to 2026
$50.4M
University of Pittsburgh Clinical Trials UnitUM1AI069494 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SUSAN L KOLETAR, John W Mellors · 2012 to 2026
$38.0M
University of Pittsburgh Clinical Trials UnitU01AI069494 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MELLORS, JOHN W · 2007 to 2011
$13.9M
Mentoring Across Disciplines: Aging and Infectious Diseases with a Focus on MobilityK24AG082527 · NIA · UNIVERSITY OF COLORADO DENVER · PI Kristine Mace Erlandson · 2023 to 2026
$768k
NIAID NIH HHS U01 AI068634NIAID NIH HHS U01 AI068636NIAID NIH HHS U01 AI069494NIAID NIH HHS UM1 AI068634NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI069432NIAID NIH HHS UM1 AI069494NIAID NIH HHS UM1 AI106701NIA NIH HHS K24 AG082527
6 · The paper itself

Abstract

Background: Potential harms of preventable/modifiable use of substances, such as cannabis, among aging people with HIV (PWH) are unclear. We characterized longitudinal associations between current cannabis use and subsequent fall risk among aging PWH. Method: Participants in the Advancing Clinical Therapeutics Globally (ACTG) A5322 study self-reported current cannabis use and any fall(s) annually and semiannually, respectively. Generalized linear models and inverse probability weighting were used to assess associations between cannabis use and subsequent fall risk, adjusting for baseline covariates (age, sex assigned at birth, and race/ethnicity), time-varying confounders, and study attrition. Results: Among 957 participants (median age, 51 years), 18.2% reported current cannabis use at baseline; 18.6% reported falling in the first year of the longitudinal study. Current cannabis use was associated with moderate risk of any falls in the following year in baseline covariate-adjusted analysis (risk ratio [RR], 1.27 95% CI, 1.02, 1.57; Conclusions: Among aging PWH, the association between current cannabis use and fall risk was primarily confounded by cigarette smoking status. Future studies should incorporate more granular cannabis use data on falls risk, including cannabis composition or strain and dose.

Indexed as

agingcannabisfallsHIVphysical function

Identifiers

PMID42582373
PMCPMC13457506

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.